Genetic Engineering of Pharmacologically Regulated T Cells, Specific for Breast Cancer Target Antigens

Breast Cancer Research - United Kingdom
doi 10.1186/bcr2548
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Genetic Engineering of T Cells for Immune Tolerance

Molecular Therapy - Methods and Clinical Development
Molecular MedicineGeneticsMolecular Biology
2020English

Identifying Environmental Antigens That Activate Myelin-Specific T Cells

Trends in Immunology
AllergyImmunology
2014English

Novel Approaches for Identifying Target Antigens of Autoreactive Human B and T Cells

Seminars in Immunopathology
AllergyImmunology
2009English

HIV-Specific T Cells: Strategies for Fighting a Moving Target

Current HIV Research
VirologyInfectious Diseases
2010English

Profiling of Estrogen-Regulated MicroRNAs in Breast Cancer Cells

Journal of Visualized Experiments
ImmunologyMolecular BiologyBiochemistryMicrobiology Chemical EngineeringNeuroscienceGenetics
2014English

Dendritic Cells Loaded With Killed Breast Cancer Cells Induce Differentiation of Tumor-Specific Cytotoxic T Lymphocytes

Breast Cancer Research
Cancer ResearchOncology
2004English

Salivary Protein Antigens for Breast Cancer Biomarkers

2019English

Genetic Redirection of T Cells for the Treatment of Pancreatic Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

More T Cells Versus Better T Cells in Patients With Breast Cancer

Cancer Discovery
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy